Production (Stage)
Cell Source, Inc.
CLCS
$0.2978
$0.01786.36%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -21.14% | -22.28% | -13.90% | 19.53% | 39.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.19% | -4.90% | -13.94% | 0.18% | 18.97% |
| Operating Income | 8.19% | 4.90% | 13.94% | -0.18% | -18.97% |
| Income Before Tax | 6.73% | 6.71% | 11.89% | -2.97% | -20.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 6.73% | 6.71% | 11.89% | -2.97% | -20.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.73% | 6.71% | 11.89% | -2.97% | -20.21% |
| EBIT | 8.19% | 4.90% | 13.94% | -0.18% | -18.97% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 12.43% | 12.10% | 15.20% | 4.30% | -9.51% |
| Normalized Basic EPS | 18.29% | 17.71% | 20.27% | 6.47% | -15.72% |
| EPS Diluted | 12.43% | 12.10% | 15.20% | 4.30% | -9.51% |
| Normalized Diluted EPS | 18.29% | 17.71% | 20.27% | 6.47% | -15.72% |
| Average Basic Shares Outstanding | 10.09% | 9.41% | 8.86% | 8.47% | 7.16% |
| Average Diluted Shares Outstanding | 10.09% | 9.41% | 8.86% | 8.47% | 7.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |